Ishan Dyes and chemicals Ltd
Ishan Dyes and Chemicals Ltd is engaged into the business of manufacturing copper phthalocyanine crude Blue (CPC Blue) and pigment blues. The products of the company are well established in the domestic and international markets.[1]
- Market Cap ₹ 105 Cr.
- Current Price ₹ 50.3
- High / Low ₹ 71.8 / 44.6
- Stock P/E 23.3
- Book Value ₹ 50.1
- Dividend Yield 0.00 %
- ROCE 2.32 %
- ROE 0.15 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.02 times its book value
- Company is expected to give good quarter
Cons
- The company has delivered a poor sales growth of 2.79% over past five years.
- Company has a low return on equity of 3.29% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.3.13 Cr.
- Promoter holding has decreased over last 3 years: -11.3%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Dyes And Pigments
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72 | 75 | 50 | 61 | 67 | 72 | 67 | 80 | 82 | 87 | 65 | 77 | 105 | |
65 | 66 | 47 | 55 | 56 | 67 | 59 | 70 | 64 | 72 | 64 | 73 | 97 | |
Operating Profit | 7 | 9 | 2 | 6 | 11 | 5 | 8 | 11 | 18 | 15 | 1 | 3 | 8 |
OPM % | 9% | 12% | 5% | 10% | 17% | 8% | 11% | 13% | 22% | 17% | 2% | 4% | 8% |
-3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 | 3 | |
Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 |
Depreciation | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
Profit before tax | -0 | 7 | 1 | 5 | 10 | 6 | 7 | 10 | 17 | 14 | -1 | 0 | 5 |
Tax % | -1,271% | 9% | -47% | 26% | 43% | 43% | 34% | 20% | 26% | 27% | -2% | 77% | |
1 | 6 | 2 | 4 | 6 | 3 | 4 | 8 | 13 | 10 | -1 | 0 | 4 | |
EPS in Rs | 0.50 | 3.88 | 1.32 | 2.35 | 3.41 | 2.05 | 2.64 | 5.14 | 8.02 | 5.96 | -0.57 | 0.06 | 2.11 |
Dividend Payout % | 0% | 0% | 0% | 10% | 0% | 25% | 0% | 19% | 16% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 3% |
3 Years: | -2% |
TTM: | 74% |
Compounded Profit Growth | |
---|---|
10 Years: | -31% |
5 Years: | -49% |
3 Years: | -77% |
TTM: | 256% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 15% |
3 Years: | -21% |
1 Year: | -19% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 8% |
3 Years: | 3% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 8 | 11 | 11 | 11 | 16 | 16 | 17 | 21 | 21 | 21 |
Reserves | 2 | 8 | 10 | 14 | 16 | 18 | 22 | 38 | 49 | 69 | 82 | 82 | 84 |
5 | 3 | 5 | 9 | 7 | 9 | 12 | 2 | 10 | 19 | 22 | 59 | 68 | |
17 | 6 | 12 | 7 | 10 | 10 | 9 | 10 | 15 | 10 | 6 | 17 | 23 | |
Total Liabilities | 31 | 25 | 34 | 36 | 44 | 48 | 55 | 67 | 90 | 114 | 131 | 179 | 197 |
8 | 7 | 12 | 13 | 12 | 20 | 26 | 29 | 31 | 37 | 62 | 64 | 64 | |
CWIP | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 30 | 38 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 16 | 22 | 24 | 31 | 27 | 29 | 37 | 59 | 77 | 68 | 85 | 94 | |
Total Assets | 31 | 25 | 34 | 36 | 44 | 48 | 55 | 67 | 90 | 114 | 131 | 179 | 197 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 5 | 4 | -1 | 4 | 7 | 5 | 3 | -2 | -9 | 20 | -9 | |
-2 | -3 | -4 | -2 | -2 | -8 | -7 | -5 | -3 | -8 | -41 | -25 | |
-1 | -2 | 0 | 3 | -2 | 0 | 2 | 3 | 5 | 16 | 20 | 34 | |
Net Cash Flow | -0 | 0 | -0 | 0 | 0 | -0 | -0 | 1 | -1 | -0 | 0 | -0 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65 | 12 | 61 | 46 | 61 | 82 | 67 | 86 | 119 | 145 | 72 | 118 |
Inventory Days | 52 | 53 | 79 | 44 | 124 | 49 | 90 | 73 | 129 | 187 | 211 | 194 |
Days Payable | 112 | 27 | 124 | 42 | 49 | 62 | 63 | 51 | 101 | 48 | 27 | 99 |
Cash Conversion Cycle | 4 | 37 | 16 | 48 | 136 | 69 | 94 | 107 | 146 | 284 | 256 | 213 |
Working Capital Days | 18 | 36 | 34 | 80 | 108 | 87 | 103 | 113 | 186 | 276 | 336 | 302 |
ROCE % | 31% | 46% | 10% | 24% | 33% | 17% | 18% | 22% | 27% | 17% | 0% | 2% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Jan - Certificate under Regulation 74(5) for Q4 2024.
- Closure of Trading Window 24 Dec
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov 2024 - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Copies of Newspaper Publications.
- Financial Results For Quarter And Half Year Ended 30Th September, 2024. 13 Nov 2024
-
Board Meeting Outcome for 13Th November 2024
13 Nov 2024 - Approval of un-audited financial results for Q2 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio
The company's product portfolio includes Piothalocyanlne Blue Range products like CPC Blue. Pigment Alpha Blue and Pigment Beta Blue. [1]